Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	A: GM-CSF + Supervised Treadmill Exercise Therapy	2	53
Total, all-cause mortality	B: GM-CSF + Attention Control Group	1	53
Total, all-cause mortality	C: Placebo + Supervised Exercise Therapy	0	53
Total, all-cause mortality	D: Placebo + Attention Control Group	0	51
Total, other adverse events	A: GM-CSF + Supervised Treadmill Exercise Therapy	52	53
Total, other adverse events	B: GM-CSF + Attention Control Group	49	53
Total, other adverse events	C: Placebo + Supervised Exercise Therapy	50	53
Total, other adverse events	D: Placebo + Attention Control Group	48	51
Total, serious adverse events	A: GM-CSF + Supervised Treadmill Exercise Therapy	17	53
Total, serious adverse events	B: GM-CSF + Attention Control Group	13	53
Total, serious adverse events	C: Placebo + Supervised Exercise Therapy	9	53
Total, serious adverse events	D: Placebo + Attention Control Group	12	51

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01408901/event-totals